 |
Download the the Pulse of CRF Late-Spring 2009 Newsletter (500 KB, PDF) |
Message from the Faculty
Gregg W. Stone, MD
Welcome to the Cardiovascular Research Foundation’s Late-Spring Newsletter. With the changing of the seasons, CRF has also experienced change. We bid a fond farewell to Marvin L. Woodall, our CEO. Throughout his career, Marv has been a highly respected leader in the interventional vascular medicine community. His experience prior to his time at CRF included serving as President of Johnson & Johnson Interventional Systems, where he led the team responsible for developing the original Palmaz-Schatz stent, the first major balloon-expandable coronary stent. He also helped initiate the research that led to the first FDA-approved drug-eluting stent.
During his time on CRF’s Board of Directors and as CEO, Marv oversaw a period of tremendous growth and helped strengthen CRF. In late April, we welcomed a new CEO, William A. Himmelsbach, who brings over three decades of leadership and management expertise to our organization. Prior to joining CRF, Bill was Senior Vice President at VHA and Executive Officer of the New York-based VHA Empire – Metro. He has also held executive positions at several hospitals and health care systems. We are confident that Bill’s extensive experience will further strengthen CRF’s role in the development of new technologies and therapies to help people with heart disease.
Meanwhile, in our more scientific endeavors, the annual meeting of the American College of Cardiology/i2 Summit in Orlando, FL, in March marked the first i2 Summit that was the product of the new partnership between CRF and ACC. The meeting was a resounding success, offering many learning opportunities to not just the traditional audience of interventionalists but also surgeons and general cardiologists. We extend our sincerest thanks to all the CRF physicians and staff who helped make this year’s i2 Summit one of the best ever.
And, as always, we continue to steam ahead in our planning for the upcoming TCT scientific symposium, which for the first time will take place in San Francisco, CA, September 21-25, 2009. With all these initiatives in the pipeline, we are looking forward to a productive and rewarding summer season at CRF. Thanks to all for your continued hard work in helping to advance our goal of helping people with heart disease everywhere.
Sincerely,
Gregg W. Stone, MD
Cardiovascular Research Foundation
